ATE354380T1 - Zusammensetzung zur prävention von infektionen durch subkutane prothesen - Google Patents

Zusammensetzung zur prävention von infektionen durch subkutane prothesen

Info

Publication number
ATE354380T1
ATE354380T1 AT03002292T AT03002292T ATE354380T1 AT E354380 T1 ATE354380 T1 AT E354380T1 AT 03002292 T AT03002292 T AT 03002292T AT 03002292 T AT03002292 T AT 03002292T AT E354380 T1 ATE354380 T1 AT E354380T1
Authority
AT
Austria
Prior art keywords
substances
antimicrobial
infections
locking
prevention
Prior art date
Application number
AT03002292T
Other languages
English (en)
Inventor
Hans-Dietrich Polaschegg
Original Assignee
Polaschegg Hans-Dietrich Dr Te
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polaschegg Hans-Dietrich Dr Te filed Critical Polaschegg Hans-Dietrich Dr Te
Application granted granted Critical
Publication of ATE354380T1 publication Critical patent/ATE354380T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0017Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/88Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms six-membered rings with three ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L29/126Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3653Interfaces between patient blood circulation and extra-corporal blood circuit
    • A61M1/3659Cannulae pertaining to extracorporeal circulation
    • A61M1/3661Cannulae pertaining to extracorporeal circulation for haemodialysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M2025/0056Catheters; Hollow probes characterised by structural features provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Pest Control & Pesticides (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Composite Materials (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agronomy & Crop Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03002292T 2003-02-03 2003-02-03 Zusammensetzung zur prävention von infektionen durch subkutane prothesen ATE354380T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03002292A EP1442753B1 (de) 2003-02-03 2003-02-03 Zusammensetzung zur Prävention von Infektionen durch subkutane Prothesen

Publications (1)

Publication Number Publication Date
ATE354380T1 true ATE354380T1 (de) 2007-03-15

Family

ID=32605301

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03002292T ATE354380T1 (de) 2003-02-03 2003-02-03 Zusammensetzung zur prävention von infektionen durch subkutane prothesen

Country Status (5)

Country Link
US (6) US20040156908A1 (de)
EP (1) EP1442753B1 (de)
AT (1) ATE354380T1 (de)
DE (1) DE60311958T2 (de)
ES (1) ES2282529T3 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81235C2 (en) 2001-11-26 2007-12-25 Genentech Inc Catheter composition and uses thereof
US20030144362A1 (en) * 2002-01-28 2003-07-31 Utterberg David S. High viscosity antibacterials for cannulae
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
EP1898990B1 (de) * 2005-05-09 2012-02-15 Medical Components, Inc. Sicherheitsspitze für gefässkatheter
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US8916148B2 (en) 2006-11-07 2014-12-23 Genentech, Inc. Tissue plasminogen activator variant uses
US8550690B2 (en) * 2007-04-13 2013-10-08 Construction Research & Technology Gmbh Method and device for dispensing liquids
US8597253B2 (en) 2007-04-20 2013-12-03 Bard Access Systems Huber needle with safety sheath
WO2010009369A2 (en) * 2008-07-17 2010-01-21 Georgia Levis Methods and materials for the treatment of acne
US8622996B2 (en) 2008-10-27 2014-01-07 Pursuit Vascular, Inc. Method for applying antimicrobial to proximal end of catheter
US9072868B2 (en) 2008-10-27 2015-07-07 Pursuit Vascular, Inc. Device for delivery of antimicrobial agent into trans-dermal catheter
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US8622995B2 (en) 2009-10-26 2014-01-07 Pursuit Vascular, Inc. Method for delivery of antimicrobial to proximal end of catheter
US9248093B2 (en) 2009-06-11 2016-02-02 Becton, Dickinson And Company Catheter locking solution having antimicrobial and anticoagulation properties
US9248234B2 (en) 2010-09-10 2016-02-02 C. R. Bard, Inc. Systems for isolation of a needle-based infusion set
US20140066894A1 (en) 2010-09-10 2014-03-06 C. R. Bard, Inc. Self-Sealing Pad for a Needle-Based Infusion Set
US10525234B2 (en) 2010-09-10 2020-01-07 C. R. Bard, Inc. Antimicrobial/haemostatic interface pad for placement between percutaneously placed medical device and patient skin
CA2817327A1 (en) 2010-11-09 2012-05-18 Frank Prosl Hemodialysis access system
CA2841832C (en) 2011-07-12 2019-06-04 Pursuit Vascular, Inc. Device for delivery of antimicrobial agent into a trans-dermal catheter
US9220814B2 (en) * 2011-09-29 2015-12-29 Ethicon, Inc. Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions
US8841640B1 (en) 2013-03-13 2014-09-23 Inceptus Technologies, Llc Apparatus for infection control
JP6359355B2 (ja) 2013-12-27 2018-07-18 株式会社クレハ 分解性を有するゴム材料から形成される拡径可能な環状のゴム部材を備える坑井掘削用プラグ
JP6359888B2 (ja) 2013-12-27 2018-07-18 株式会社クレハ ダウンホールツール用の拡径可能な環状の分解性シール部材、及び坑井掘削用プラグ、並びに坑井掘削方法
AU2015218703A1 (en) 2014-02-21 2016-09-22 Avadim Technologies, Inc. Method for maintenance of urethral catheters
CN106030023B (zh) 2014-03-07 2019-07-30 株式会社吴羽 钻井工具用分解性橡胶构件、分解性密封构件、分解性保护构件、钻井工具、以及钻井方法
JP6363362B2 (ja) 2014-03-11 2018-07-25 株式会社クレハ 炭化水素資源回収用ダウンホールツール部材
US10046156B2 (en) 2014-05-02 2018-08-14 Excelsior Medical Corporation Strip package for antiseptic cap
CA2968525A1 (en) 2014-11-19 2016-05-26 Avadim Technologies, Inc. Method for the prevention and treatment of acne
JP6822978B2 (ja) 2015-05-08 2021-01-27 アイシーユー・メディカル・インコーポレーテッド 治療薬のエミッタを受け入れるように構成された医療用コネクタ
PL3525865T3 (pl) 2016-10-14 2023-02-06 Icu Medical, Inc. Nasadki dezynfekcyjne dla łączników medycznych
JP7138110B2 (ja) * 2017-01-05 2022-09-15 コーメディクス・インコーポレーテッド 成熟バイオフィルムに対して有効な、抗菌ヒドロゲルを含む抗菌組成物
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
WO2019023617A1 (en) 2017-07-27 2019-01-31 University Of Utah Research Foundation DEVICE FOR DELIVERY OF THERAPEUTIC PRODUCT
JP7138702B2 (ja) 2017-09-22 2022-09-16 ベクトン・ディキンソン・アンド・カンパニー カテーテルロック溶液としての使用のための4%クエン酸三ナトリウム溶液
AU2019330831A1 (en) * 2018-08-28 2021-04-29 Cormedix Inc. Methods and compositions for treating neuroblastoma in a juvenile mammalian body
CN113347976A (zh) * 2018-08-28 2021-09-03 科医公司 用牛磺罗定水解产物进行的神经母细胞瘤治疗
US10525250B1 (en) 2018-11-07 2020-01-07 Pursuit Vascular, Inc. Infusion device with antimicrobial properties
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
CN109529096A (zh) * 2018-11-21 2019-03-29 深圳麦普奇医疗科技有限公司 一种均匀粒径明胶栓塞剂及其制备方法
US11433215B2 (en) 2018-11-21 2022-09-06 Icu Medical, Inc. Antimicrobial device comprising a cap with ring and insert
CN111184918B (zh) * 2020-01-07 2022-04-26 江苏百赛飞生物科技有限公司 具有抗菌涂层的曲面造型医疗器械及其制备方法
EP4255552A1 (de) 2020-12-07 2023-10-11 ICU Medical, Inc. Peritonealdialysekappen, systeme und verfahren
US11147959B1 (en) 2021-03-31 2021-10-19 Jason Lakis Syringe apparatus for disinfection of central line port needleless connector and method of disinfecting a central line port needleless connector
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
US3963832A (en) * 1973-01-24 1976-06-15 Teijin Limited Liquid or pasty dentifrice and process for its preparation
CA1190855A (en) * 1980-09-03 1985-07-23 Rolf W. Pfirrmann Treatment of osteitis
DE3506288A1 (de) * 1984-09-06 1986-03-13 Johannes 7900 Ulm Reinmüller Vorrichtung zum einlegen in wunden und wundhoehlen
US4621120A (en) * 1985-04-01 1986-11-04 Eastman Kodak Company Polymeric antibacterial compositions
GB8514052D0 (en) * 1985-06-04 1985-07-10 Geistlich Soehne Ag Compositions
GB8514055D0 (en) * 1985-06-04 1985-07-10 Geistlich Soehne Ag Chemical substance
US4587284A (en) * 1985-06-14 1986-05-06 Ed. Geistlich Sohne Ag Fur Chemische Industrie Absorbent polymer material and its preparation
DE3533612A1 (de) * 1985-09-20 1987-04-02 Johannes Reinmueller Neuartige verwendung von taurolin
EP0262343B1 (de) * 1986-08-07 1996-01-03 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG N-alkylierte quartäre stickstoffhaltige Heterozyklen, Verfahren zu deren Herstellung und deren Verwendung in Arzneimitteln
US5573771A (en) * 1988-08-19 1996-11-12 Osteomedical Limited Medicinal bone mineral products
ES2063309T3 (es) * 1989-07-12 1995-01-01 Oreal Derivados de pirimidina 3-oxido halogenados, su utilizacion para el tratamiento y la prevencion de la caida de los cabellos y para estimular su crecimiento.
CA2125167A1 (en) * 1991-12-06 1993-06-10 North Shore University Hospital Research Corporation Method of reducing medical device related infections
GB9216155D0 (en) * 1992-07-30 1992-09-09 Geistlich Soehne Ag Treatment of dentoalveolar infections
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6558798B2 (en) * 1995-02-22 2003-05-06 Scimed Life Systems, Inc. Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity
US6179817B1 (en) * 1995-02-22 2001-01-30 Boston Scientific Corporation Hybrid coating for medical devices
US5869127A (en) * 1995-02-22 1999-02-09 Boston Scientific Corporation Method of providing a substrate with a bio-active/biocompatible coating
US6468649B1 (en) * 1995-02-22 2002-10-22 Scimed Life Systems, Inc. Antimicrobial adhesion surface
US6231600B1 (en) * 1995-02-22 2001-05-15 Scimed Life Systems, Inc. Stents with hybrid coating for medical devices
US5702754A (en) * 1995-02-22 1997-12-30 Meadox Medicals, Inc. Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings
US5578119A (en) * 1995-06-06 1996-11-26 Microsome Moldable sculpting medium
US5721306A (en) * 1995-06-07 1998-02-24 Amcol International Corporation Viscous carrier compositions, including gels, formed with an organic liquid carrier and a layered material:polymer complex
EP0949905B1 (de) * 1996-12-20 2001-07-18 Alza Corporation Injizierbare depotgelzubereitung und herstellungsverfahren
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
US6299609B1 (en) * 1998-01-07 2001-10-09 Vasca, Inc. Methods and apparatus for inhibiting infection of subcutaneously implanted devices
US6436084B1 (en) * 1998-01-07 2002-08-20 Vasca, Inc. Methods and apparatus for disinfecting subcutaneously implanted devices
US6299610B1 (en) * 1998-01-07 2001-10-09 Vasca, Inc. Methods and apparatus for disinfecting subcutaneously implanted devices
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6958049B1 (en) * 1998-08-25 2005-10-25 Ash Access Technology, Inc. Method of enhancing catheter patency using a citrate salt catheter lock solution
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
CA2302720C (en) * 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6297337B1 (en) * 1999-05-19 2001-10-02 Pmd Holdings Corp. Bioadhesive polymer compositions
US6685694B2 (en) * 1999-07-23 2004-02-03 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
KR20010016065A (ko) * 1999-11-29 2001-03-05 울프 크라스텐센, 스트라쎄 로텐베르그 1,1-디옥소퍼히드로-1,2,4-티아디아진의 용도
IL133969A0 (en) * 2000-01-10 2001-04-30 Thixo Ltd Thixotropic compositions containing unsaturated oils and food products containing the same
US6967023B1 (en) * 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6350251B1 (en) * 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US6306419B1 (en) * 2000-02-23 2001-10-23 Aegis Biosciences, Llc Medical uses of styrene sulfonate polymers
US6451003B1 (en) * 2000-08-16 2002-09-17 Biolink Corporation Method and apparatus for overcoming infection in a tissue pocket surrounding an implanted device
CA2445740A1 (en) * 2001-04-23 2002-10-31 Nucryst Pharmaceuticals Corp. Use of metals to treat inflammatory skin conditions
ES2329346T3 (es) * 2001-11-14 2009-11-25 Durect Corporation Composicion de deposito inyectable.
EP1446101B1 (de) * 2001-11-14 2011-03-23 Durect Corporation Katheterinjizierbare depotzusammensetzungen und deren verwendung
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
US20030144362A1 (en) * 2002-01-28 2003-07-31 Utterberg David S. High viscosity antibacterials for cannulae
US20030180347A1 (en) * 2002-03-19 2003-09-25 W.F. Young, Incorporated Patch for the delivery of topical agents
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US20060140988A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Visco-supplement composition and methods

Also Published As

Publication number Publication date
US20100145252A1 (en) 2010-06-10
US20130190724A1 (en) 2013-07-25
DE60311958T2 (de) 2007-11-08
DE60311958D1 (de) 2007-04-05
ES2282529T3 (es) 2007-10-16
US20130183363A1 (en) 2013-07-18
EP1442753A1 (de) 2004-08-04
EP1442753B1 (de) 2007-02-21
US20130172260A1 (en) 2013-07-04
US20040156908A1 (en) 2004-08-12
US20100145251A1 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
ATE354380T1 (de) Zusammensetzung zur prävention von infektionen durch subkutane prothesen
JP7486557B2 (ja) バクテリア混入を防止するための半固体組成物
KR102160314B1 (ko) 잔류하는 차단 막을 포함하는 항균 조성물
EP3113621B1 (de) Katheter-lock-lösungsformulierungen
ES2645681T3 (es) Composiciones antimicrobianas y métodos para bloquear catéteres
ES2565511T3 (es) Composiciones antisépticas, procedimientos y sistemas
ES2951567T3 (es) Disoluciones antimicrobianas de bloqueo que comprenden derivados de taurinamida, y sales y ácidos biológicamente aceptables, con la adición de bajas concentraciones de heparina
PT1688154E (pt) Solução de bloqueio para cateter com citrato e parabeno
US20100010086A1 (en) Antimicrobial therapy for indwelling catheters and for sanitizing surfaces
Cambiaso-Daniel et al. Topical antimicrobials in burn care: Part 1—topical antiseptics
ATE345130T1 (de) Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen
JPH0414992B2 (de)
KR20080021133A (ko) 항균 비구아니드 금속 착체
EP1284780B1 (de) Kathetersperrlösung mit photo-oxidant
CA2628806A1 (en) Injectable liquid paracetamol formulation
WO2009085318A1 (en) Disinfectant compositions, methods and systems
JP2005507395A5 (de)
BRPI0416387A (pt) composição desinfetante e métodos de confecção e uso da mesma
WO2009085317A1 (en) Disinfectant compositions, methods and systems
US20170281824A1 (en) Anti-Microbial Medical Materials and Devices
US20110159462A1 (en) Therapeutic agent for periodontal diseases and method of treating periodontal diseases
EP0450117A1 (de) Ringerlösung und dessen Anwendung als bakterizid wirkendes lokales Wundbehandlungsmedikament
Twardowski et al. Peritoneal dialysis access and exit site care
EP2366397A1 (de) Essigsäure enthaltende verschlusslösung für einen intravaskulären verweilkatheter und diese enthaltender behälter
ES2971830T3 (es) Formulación

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties